Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020
Fewer PCIs and higher mortality: a new snapshot captures three pandemic waves and renews talk of COVID’s collateral damage.
Fewer PCIs and higher mortality: a new snapshot captures three pandemic waves and renews talk of COVID’s collateral damage.
Two physicians at ISET 2024 shared their firsthand impressions of what AI can bring to PE diagnosis, triage, and treatment.
The trial, though not powered for clinical outcomes, hints at yet another setting where it may be possible to leave nothing behind.
Harmony Reynolds, MD, explores sex differences in the ISCHEMIA trial related to treatment and risk factor control.
Recent US registry data show that while most patients resemble those in key trials, just one in six get all four pillars of GDMT.
The injectable activin signaling inhibitor is the first of this class to be approved by the FDA and is meant to be given every 3…
Surgeons who have, for decades, been advocating for multiarterial grafts say it’s time for outdated habits to change.
The search for a therapy that reduces Lp(a)-specific risk continues. Multiple options are in the pipeline.
Imaging allows “us to ‘measure twice, cut once,’ ensuring the highest level of precision in these critical interventions,” Ahmed Bendary says.
As researchers learn more about the link between pregnancy complications and CV risk, lifestyle modifications may prove key.
To pick the right one, clinicians should be familiar with the similarities and differences of the newly approved tools.